Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.

Dovc K, Piona C, Yeşiltepe Mutlu G, Bratina N, Jenko Bizjan B, Lepej D, Nimri R, Atlas E, Muller I, Kordonouri O, Biester T, Danne T, Phillip M, Battelino T.

Diabetes Care. 2019 Oct 1. pii: dc190895. doi: 10.2337/dc19-0895. [Epub ahead of print]

PMID:
31575640
2.

Determinants of glycaemic outcome in the current practice of care for young people up to 21 years old with type 1 diabetes under real-life conditions.

Kordonouri O, Lange K, Biester T, Datz N, Kapitzke K, von dem Berge T, Weiskorn J, Danne T.

Diabet Med. 2019 Sep 9. doi: 10.1111/dme.14130. [Epub ahead of print]

PMID:
31498923
3.

Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol.

Ziegler AG, Achenbach P, Berner R, Casteels K, Danne T, Gündert M, Hasford J, Hoffmann VS, Kordonouri O, Lange K, Elding Larsson H, Lundgren M, Snape MD, Szypowska A, Todd JA, Bonifacio E; and the GPPAD Study group.

BMJ Open. 2019 Jun 28;9(6):e028578. doi: 10.1136/bmjopen-2018-028578.

4.

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results.

Winkler C, Haupt F, Heigermoser M, Zapardiel-Gonzalo J, Ohli J, Faure T, Kalideri E, Hommel A, Delivani P, Berner R, Kordonouri O, Roloff F, von dem Berge T, Lange K, Oltarzewski M, Glab R, Szypowska A, Snape MD, Vatish M, Todd JA, Larsson HE, Ramelius A, Kördel JÅ, Casteels K, Paulus J, Ziegler AG, Bonifacio E; GPPAD Study Group.

Pediatr Diabetes. 2019 Sep;20(6):720-727. doi: 10.1111/pedi.12870. Epub 2019 Jun 13.

PMID:
31192505
5.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M.

Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8. Review.

6.

Beyond type 2 diabetes: sodium glucose co-transporter-inhibition in type 1 diabetes.

Biester T, Kordonouri O, Danne T.

Diabetes Obes Metab. 2019 Apr;21 Suppl 2:53-61. doi: 10.1111/dom.13659.

PMID:
31081591
7.

Use of apps for physical activity in type 1 diabetes: current status and requirements for future development.

Kordonouri O, Riddell MC.

Ther Adv Endocrinol Metab. 2019 Apr 17;10:2042018819839298. doi: 10.1177/2042018819839298. eCollection 2019. Review.

8.

Diagnosis, Therapy and Follow-up of Diabetes Mellitus in Children and Adolescents.

Neu A, Bürger-Büsing J, Danne T, Dost A, Holder M, Holl RW, Holterhus PM, Kapellen T, Karges B, Kordonouri O, Lange K, Müller S, Raile K, Schweizer R, Sengbusch SV, Stachow R, Wagner V, Wiegand S, Ziegler R.

Exp Clin Endocrinol Diabetes. 2019 Jun;127(6):341-352. doi: 10.1055/a-0869-0210. Epub 2019 Apr 29. No abstract available.

PMID:
31035299
9.

Setting the right course at type 1 diabetes diagnosis.

Lange K, Kordonouri O.

Lancet Child Adolesc Health. 2019 Mar;3(3):138-139. doi: 10.1016/S2352-4642(19)30031-8. Epub 2019 Jan 29. No abstract available.

PMID:
30704874
10.

New approach for detection of LDL-hypercholesterolemia in the pediatric population: The Fr1dolin-Trial in Lower Saxony, Germany.

Kordonouri O, Lange K, Boettcher I, Christoph J, Marquardt E, Tombois C, Galuschka L, Stiller D, Mueller I, Roloff F, Aschemeier B, Danne T.

Atherosclerosis. 2019 Jan;280:85-91. doi: 10.1016/j.atherosclerosis.2018.11.011. Epub 2018 Nov 17.

PMID:
30496984
11.

DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.

Biester T, Nir J, Remus K, Farfel A, Muller I, Biester S, Atlas E, Dovc K, Bratina N, Kordonouri O, Battelino T, Philip M, Danne T, Nimri R.

Diabetes Obes Metab. 2018 Nov 26. doi: 10.1111/dom.13585. [Epub ahead of print]

PMID:
30478937
12.

Physical activity is associated with lower insulin and C-peptide during glucose challenge in children and adolescents with family background of diabetes.

Ungethüm K, Jolink M, Hippich M, Lachmann L, Haupt F, Winkler C, Hummel S, Pitchika A, Kordonouri O, Ziegler AG, Beyerlein A.

Diabet Med. 2019 Mar;36(3):366-375. doi: 10.1111/dme.13819. Epub 2018 Oct 26.

PMID:
30242901
13.

Transition of care for young adults with chronic diseases.

Kordonouri O.

Lancet Child Adolesc Health. 2017 Dec;1(4):251-253. doi: 10.1016/S2352-4642(17)30102-5. Epub 2017 Oct 5. No abstract available.

PMID:
30169176
14.

The influence of treatment, age at onset, and metabolic control on height in children and adolescents with type 1 diabetes-A SWEET collaborative study.

Svensson J, Schwandt A, Pacaud D, Beltrand J, Birkebaek NH, Cardona-Hernandez R, Casteels K, Castro S, Cherubini V, Cody D, Fisch N, Hasnani D, Kordonouri O, Kosteria I, Luczay A, Pundziute-Lyckå A, Maffeis C, Piccini B, Luxmi P, Sumnik Z, de Beaufort C.

Pediatr Diabetes. 2018 Dec;19(8):1441-1450. doi: 10.1111/pedi.12751. Epub 2018 Oct 10.

PMID:
30105887
15.

ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes.

Mahmud FH, Elbarbary NS, Fröhlich-Reiterer E, Holl RW, Kordonouri O, Knip M, Simmons K, Craig ME.

Pediatr Diabetes. 2018 Oct;19 Suppl 27:275-286. doi: 10.1111/pedi.12740. No abstract available.

16.

Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study.

Campbell FM, Murphy NP, Stewart C, Biester T, Kordonouri O.

Pediatr Diabetes. 2018 Nov;19(7):1294-1301. doi: 10.1111/pedi.12735. Epub 2018 Aug 29.

PMID:
30054967
17.

Associations of maternal type 1 diabetes with childhood adiposity and metabolic health in the offspring: a prospective cohort study.

Pitchika A, Jolink M, Winkler C, Hummel S, Hummel N, Krumsiek J, Kastenmüller G, Raab J, Kordonouri O, Ziegler AG, Beyerlein A.

Diabetologia. 2018 Nov;61(11):2319-2332. doi: 10.1007/s00125-018-4688-x. Epub 2018 Jul 14.

PMID:
30008062
18.

Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care.

Danne T, Biester T, Kordonouri O.

Diabetes Technol Ther. 2018 Jun;20(S2):S269-S277. doi: 10.1089/dia.2018.0081.

PMID:
29916741
19.

Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians.

Nimri R, Dassau E, Segall T, Muller I, Bratina N, Kordonouri O, Bello R, Biester T, Dovc K, Tenenbaum A, Brener A, Šimunović M, Sakka SD, Nevo Shenker M, Passone CG, Rutigliano I, Tinti D, Bonura C, Caiulo S, Ruszala A, Piccini B, Giri D, Stein R, Rabbone I, Bruzzi P, Omladič JŠ, Steele C, Beccuti G, Yackobovitch-Gavan M, Battelino T, Danne T, Atlas E, Phillip M.

Diabetes Obes Metab. 2018 Oct;20(10):2458-2466. doi: 10.1111/dom.13408. Epub 2018 Jul 18.

PMID:
29885025
20.

Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?

Biester T, Kordonouri O, Danne T.

Ther Adv Endocrinol Metab. 2018 May;9(5):157-166. doi: 10.1177/2042018818763247. Epub 2018 Mar 19. Review.

21.

Editorial Tribute: Mark A. Sperling, MD, Editor-in-Chief, Pediatric Diabetes 2000-2017.

Menon R, Becker D, Arslanian S, Kordonouri O, Trucco M, Pietropaolo M, Danne T.

Pediatr Diabetes. 2018 May;19(3):345. doi: 10.1111/pedi.12661. No abstract available.

PMID:
29695032
22.

Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.

Writing Group for the TRIGR Study Group, Knip M, Åkerblom HK, Al Taji E, Becker D, Bruining J, Castano L, Danne T, de Beaufort C, Dosch HM, Dupre J, Fraser WD, Howard N, Ilonen J, Konrad D, Kordonouri O, Krischer JP, Lawson ML, Ludvigsson J, Madacsy L, Mahon JL, Ormisson A, Palmer JP, Pozzilli P, Savilahti E, Serrano-Rios M, Songini M, Taback S, Vaarala O, White NH, Virtanen SM, Wasikowa R.

JAMA. 2018 Jan 2;319(1):38-48. doi: 10.1001/jama.2017.19826.

23.

International Consensus on Use of Continuous Glucose Monitoring.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M.

Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. Review.

24.

Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.

Karges B, Schwandt A, Heidtmann B, Kordonouri O, Binder E, Schierloh U, Boettcher C, Kapellen T, Rosenbauer J, Holl RW.

JAMA. 2017 Oct 10;318(14):1358-1366. doi: 10.1001/jama.2017.13994.

25.

Pharmacological Properties of Faster-Acting Insulin Aspart.

Biester T, Kordonouri O, Danne T.

Curr Diab Rep. 2017 Sep 23;17(11):101. doi: 10.1007/s11892-017-0931-y. Review.

PMID:
28940145
26.

Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial.

Dovc K, Macedoni M, Bratina N, Lepej D, Nimri R, Atlas E, Muller I, Kordonouri O, Biester T, Danne T, Phillip M, Battelino T.

Diabetologia. 2017 Nov;60(11):2157-2167. doi: 10.1007/s00125-017-4395-z. Epub 2017 Aug 24.

27.

[Attaching an Insulin Pump].

Biester T, Biester S, Kordonouri O, Danne T.

Dtsch Med Wochenschr. 2017 May;142(10):758-762. doi: 10.1055/s-0042-119235. Epub 2017 May 17. German. No abstract available.

PMID:
28514824
28.

[The Way to Closed Loop - Dream and Reality].

Biester T, Danne T, Kordonouri O.

Dtsch Med Wochenschr. 2017 May;142(10):731-736. doi: 10.1055/s-0042-119492. Epub 2017 May 17. German.

PMID:
28514821
29.

Effects of dapagliflozin on insulin-requirement, glucose excretion and ß-hydroxybutyrate levels are not related to baseline HbA1c in youth with type 1 diabetes.

Biester T, Aschemeier B, Fath M, Frey M, Scheerer MF, Kordonouri O, Danne T.

Diabetes Obes Metab. 2017 Nov;19(11):1635-1639. doi: 10.1111/dom.12975. Epub 2017 Jun 22.

PMID:
28417527
30.

Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus.

Fath M, Danne T, Biester T, Erichsen L, Kordonouri O, Haahr H.

Pediatr Diabetes. 2017 Dec;18(8):903-910. doi: 10.1111/pedi.12506. Epub 2017 Feb 6.

PMID:
28165180
31.

Striving for control: lessons learned from a successful international Type 1 Diabetes Youth Challenge.

Kordonouri O, Vazeou A, Scharf M, Würsig M, Battelino T; SWEET Group.

Acta Diabetol. 2017 Apr;54(4):403-409. doi: 10.1007/s00592-017-0964-3. Epub 2017 Feb 2.

PMID:
28154987
32.

"Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.

Biester T, Kordonouri O, Holder M, Remus K, Kieninger-Baum D, Wadien T, Danne T.

Diabetes Technol Ther. 2017 Mar;19(3):173-182. doi: 10.1089/dia.2016.0349. Epub 2017 Jan 18.

33.

Possibilities and challenges of a large international benchmarking in pediatric diabetology-The SWEET experience.

Witsch M, Kosteria I, Kordonouri O, Alonso G, Archinkova M, Besancon S, Birkebæk NH, Bratina N, Cherubini V, Hanas R, Hasnani D, Iotova V, Raposo JF, Schwandt A, Sumnik Z, Svensson J, Veeze H; SWEET Group.

Pediatr Diabetes. 2016 Oct;17 Suppl 23:7-15. doi: 10.1111/pedi.12432. Review.

PMID:
27982492
34.

MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trial.

Nimri R, Bratina N, Kordonouri O, Avbelj Stefanija M, Fath M, Biester T, Muller I, Atlas E, Miller S, Fogel A, Phillip M, Danne T, Battelino T.

Diabetes Obes Metab. 2017 Apr;19(4):553-561. doi: 10.1111/dom.12852. Epub 2017 Jan 19.

PMID:
27981804
35.

Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years.

Danne T, Biester T, Kapitzke K, Jacobsen SH, Jacobsen LV, Petri KCC, Hale PM, Kordonouri O.

J Pediatr. 2017 Feb;181:146-153.e3. doi: 10.1016/j.jpeds.2016.10.076. Epub 2016 Dec 13.

36.

Real-time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis.

Benkhadra K, Alahdab F, Tamhane S, Wang Z, Prokop LJ, Hirsch IB, Raccah D, Riveline JP, Kordonouri O, Murad MH.

Clin Endocrinol (Oxf). 2017 Mar;86(3):354-360. doi: 10.1111/cen.13290. Epub 2017 Jan 16. Review.

PMID:
27978595
37.

Pharmacokinetic and prandial pharmacodynamic properties of insulin degludec/insulin aspart in children, adolescents, and adults with type 1 diabetes.

Biester T, Danne T, Bläsig S, Remus K, Aschemeier B, Kordonouri O, Bardtrum L, Haahr H.

Pediatr Diabetes. 2016 Dec;17(8):642-649. doi: 10.1111/pedi.12358. Epub 2016 Jan 18.

PMID:
26782928
38.

Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose-adjusted HbA1c in 3657 children and adolescents from Germany and Austria.

Nagl K, Hermann JM, Plamper M, Schröder C, Dost A, Kordonouri O, Rami-Merhar B, Holl RW.

Pediatr Diabetes. 2017 Sep;18(6):428-434. doi: 10.1111/pedi.12413. Epub 2016 Jul 15.

PMID:
27416952
39.

Seasonality at the clinical onset of type 1 diabetes-Lessons from the SWEET database.

Gerasimidi Vazeou A, Kordonouri O, Witsch M, Hermann JM, Forsander G, de Beaufort C, Veeze HJ, Maffeis C, Cherubini V, Cinek O, Piccini B, Holl RW, Danne T; SWEET Study Group.

Pediatr Diabetes. 2016 Oct;17 Suppl 23:32-37. doi: 10.1111/pedi.12433.

PMID:
28334496
40.

Reduced Worries of Hypoglycaemia, High Satisfaction, and Increased Perceived Ease of Use after Experiencing Four Nights of MD-Logic Artificial Pancreas at Home (DREAM4).

Ziegler C, Liberman A, Nimri R, Muller I, Klemenčič S, Bratina N, Bläsig S, Remus K, Phillip M, Battelino T, Kordonouri O, Danne T, Lange K.

J Diabetes Res. 2015;2015:590308. doi: 10.1155/2015/590308. Epub 2015 Oct 25.

41.

Lipoatrophy in children with type 1 diabetes: an increasing incidence?

Kordonouri O, Biester T, Schnell K, Hartmann R, Tsioli C, Fath M, Datz N, Danne T.

J Diabetes Sci Technol. 2015 Mar;9(2):206-8. doi: 10.1177/1932296814558348. Epub 2014 Nov 18.

42.

[Closed-Loop at night for the treatment of type 1 diabetes].

Danne T, Kordonouri O.

Dtsch Med Wochenschr. 2014 Oct;139(42):2156. doi: 10.1055/s-0034-1387318. Epub 2014 Oct 7. Review. German.

PMID:
25289927
43.

ISPAD Clinical Practice Consensus Guidelines 2014. Other complications and diabetes-associated conditions in children and adolescents.

Kordonouri O, Klingensmith G, Knip M, Holl RW, Aanstoot HJ, Menon PS, Craig ME; International Society for Pediatric and Adolescent Diabetes.

Pediatr Diabetes. 2014 Sep;15 Suppl 20:270-8. doi: 10.1111/pedi.12183. No abstract available.

PMID:
25182319
44.

MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial.

Nimri R, Muller I, Atlas E, Miller S, Fogel A, Bratina N, Kordonouri O, Battelino T, Danne T, Phillip M.

Diabetes Care. 2014 Nov;37(11):3025-32. doi: 10.2337/dc14-0835. Epub 2014 Jul 30.

PMID:
25078901
45.

Diagnosis, therapy and control of diabetes mellitus in children and adolescents.

Neu A, Beyer P, Bürger-Büsing J, Danne T, Etspüler J, Heidtmann B, Holl RW, Karges B, Kiess W, Knerr I, Kordonouri O, Lange K, Lepler R, Marg W, Näke A, Petersen M, Podeswik A, Stachow R, von Sengbusch S, Wagner V, Ziegler R, Holterhus PM; German Diabetes Association.

Exp Clin Endocrinol Diabetes. 2014 Jul;122(7):425-34. doi: 10.1055/s-0034-1366384. Epub 2014 Jul 11. No abstract available.

PMID:
25014094
46.

Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.

Knip M, Åkerblom HK, Becker D, Dosch HM, Dupre J, Fraser W, Howard N, Ilonen J, Krischer JP, Kordonouri O, Lawson ML, Palmer JP, Savilahti E, Vaarala O, Virtanen SM; TRIGR Study Group.

JAMA. 2014 Jun 11;311(22):2279-87. doi: 10.1001/jama.2014.5610.

47.

[Islet cell autoimmunity in diabetes: we know what we don't know].

Kordonouri O.

Dtsch Med Wochenschr. 2014 May;139(21):1105. doi: 10.1055/s-0034-1370045. Epub 2014 May 13. German. No abstract available.

PMID:
24823977
48.

Evaluating the diet of children at increased risk for type 1 diabetes: first results from the TEENDIAB study.

Weber KS, Raab J, Haupt F, Aschemeier B, Wosch A, Ried C, Kordonouri O, Ziegler AG, Winkler C.

Public Health Nutr. 2015 Jan;18(1):50-8. doi: 10.1017/S1368980013003406. Epub 2014 Jan 2.

PMID:
24476676
49.

Insulin degludec's ultra-long pharmacokinetic properties observed in adults are retained in children and adolescents with type 1 diabetes.

Biester T, Blaesig S, Remus K, Aschemeier B, Kordonouri O, Granhall C, Søndergaard F, Kristensen NR, Haahr H, Danne T.

Pediatr Diabetes. 2014 Feb;15(1):27-33. doi: 10.1111/pedi.12116.

PMID:
24467565
50.

The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise.

Danne T, Tsioli C, Kordonouri O, Blaesig S, Remus K, Roy A, Keenan B, Lee SW, Kaufman FR.

Diabetes Technol Ther. 2014 Jun;16(6):338-47. doi: 10.1089/dia.2013.0327. Epub 2014 Jan 21.

PMID:
24447074

Supplemental Content

Loading ...
Support Center